Medical marijuana has been legalized in some states in the United States due to its potential ability in treating some ailments.
The weed is cultivated and grown by some specific licensed distributors.
However, in a recently concluded study, facts have shown that not all dispensaries that are licensed to recommend medical marijuana to ailing patients actually have staff members that have the adequate medical training.
Published in the “Cannabis and Cannabinoid Research” which was led by a team of experts from Stanford University, results of the study revealed that majority of budtenders at dispensaries that recommend doses of medical marijuana had no adequate training on the weed.
Most of these dispensary staff members could not offer informed recommendations of medical marijuana to individuals who required the medical advice.
The study was conducted on a survey of at least 55 dispensary staffers that were in 9 different states.
Only about 94% of them would provide specific medical marijuana advice to ailing patients.
Out of the 94%, only about 55% were proven to have some form of formal training.
39% actually had no clue or any medical know-how required to give accurate cannabis advice.
This was found to be alarming because the weed plant itself has been proven to contain over 500 chemical compounds; this including the two cannabis compounds that doctors and experts say have side effects.
The two compounds, tetrahydrocannabinol, also known as THC, and CBD, were the two cannabinoids that were proven to have medicinal effects.
The rest of the compounds present in the cannabis when exposed to certain conditions and consumed in high doses break down to thousands of compounds and by-products which researchers have attributed to have carcinogenic effects on the user.
The people who administer the doses of medical marijuana just based on trial and error and not sound medical training are risking the lives of individuals who come relying on the cannabis for treatment.
The research conducted by Stanford University experts also involved the respondents who participated in the study to write down some of the recommendations they would give to patients requiring doses of medical marijuana.
The results revealed that dispensary staffers were probably going to advise a 1:1 ratio of THC:CBD to patients with anxiety or trauma than high THC, and also recommend a higher dosage of CBD to patients with arthritis.
Some recommendations given by dispensary staff were reliable, according to the research analysis.
The inconsistency in the medical guide on administering cannabis is partly to blame for the irregularities and confusion in the staffers when it came to issuing the correct dosage of medical marijuana to patients.
A good example is a clause in the medical information prescribing Sativa for sleep disorders, while another guide, prescribed indica.
This causes inconsistency in the weed recommendations.
It required medical personnel or skilled physicians who have experience in dealing with medical marijuana to be able to know the correct dosage to be administered to patients.
The study concluded that various states should come up with laws and regulations that require continuous training for those providing advice to patients.
The research study has shown that it is important for medical marijuana to be recommended by personnel who are conversant and experienced in handling marijuana products.
While it is expected that specific recommendations of marijuana products should be administered by doctors who are trained and have a good understanding of the patient’s medical history, it is the dispensary staffers who are mostly providing cannabis advice to patients.
States should enact laws that require some form of educational certification for those individuals giving cannabis advice to patients.
Untrained personnel selling or recommending weed based on guess work, risk the lives of patients due to the possible side effects that higher doses of marijuana has.
Latest posts by Richard (see all)
- Federal Agents and Boston Police Seize More Than 33 Pounds of Fentanyl - February 22, 2018
- Litecoin Emerges as the Next Dominant Cryptocurrency on Dark Web, Study Shows - February 21, 2018
- Spectrecoin Cryptocurrency - February 20, 2018